Pyxa Pharmaceuticals
PrivateCompany Overview
Pyxa Pharmaceuticals operates in Healthcare & Life Sciences and is based in China.
Pyxa Pharmaceuticals is a biopharmaceutical company that develops CDK2-selective small molecule inhibitors for the treatment of metastatic breast cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pyxa Pharmaceuticals Comparables
Compare Pyxa Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Incyclix Bio | 84% | |
| Avenzo Therapeutics | 80% | |
| Servier | 76% |
For institutional investors. Book with your work email.
Pyxa Pharmaceuticals Funding Rounds
Historical fundraising activity
Pyxa Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pyxa Pharmaceuticals's valuation, stock price, and market status.
Is Pyxa Pharmaceuticals a public or private company?
Pyxa Pharmaceuticals is a private company.
What is the current stock price of Pyxa Pharmaceuticals?
Pyxa Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Pyxa Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pyxa Pharmaceuticals worth (valuation)?
Valuation information for Pyxa Pharmaceuticals is not publicly available.
Can I buy Pyxa Pharmaceuticals stock?
Pyxa Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pyxa Pharmaceuticals's last funding round?
Funding round information for Pyxa Pharmaceuticals is not publicly available.
Who are the main investors in Pyxa Pharmaceuticals?
Investor information for Pyxa Pharmaceuticals is not publicly disclosed.
Will Pyxa Pharmaceuticals IPO soon?
No public IPO plans have been announced for Pyxa Pharmaceuticals.
How can I track Pyxa Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Pyxa Pharmaceuticals's shares on secondary markets.